Robert Galinsky
Dr Robert Galinsky is a developmental neuroscientist working to prevent brain injury in babies before and shortly after birth. His research focuses on understanding how inflammation, infection and oxygen deprivation disrupt brain development, and translating these discoveries into new treatments and monitoring technologies.
As Head of the Fetal and Newborn Brain Physiology Laboratory, he leads a multidisciplinary team developing innovative approaches to detect, prevent and repair brain injury in the fetus and newborn. His work has contributed to international neuroprotection research, informed clinical practice and advanced new therapies aimed at reducing lifelong disabilities such as cerebral palsy.
His current research spans anti-inflammatory therapies, biomarker discovery and next-generation perinatal brain monitoring, including the development of technology designed to directly assess fetal brain health during pregnancy and labour. Ultimately, his goal is to ensure that every child has the healthiest possible start to life.
Dr Robert Galinsky is accepting graduate students applications (Honours / Masters / PhD). Please email robert.galinsky@hudson.org.au for further information. Find out more from Dr Robert Galinsky's Monash profile.
Selected publications
- Galinsky R, Dhillon SK, Kelly SB, Wassink G, Davidson JO, Lear CA, van den Heuij LG, Bennet L, Gunn AJ (2023). Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep. J Physiol. 2023 Mar 31.
- Green EA, Metz D, Galinsky R, Atkinson R, Skuza EM, Clark M, Gunn AJ, Kirkpatrick CM, Hunt RW, Berger PJ, Nold-Petry CA, Nold MF (2022). Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants. Front Immunol. 2022 Oct 27;13:1022104.
- Kelly SB, Green E, Hunt RW, Nold-Petry CA, Gunn AJ, Nold MF, Galinsky R (2023). Interleukin-1: an important target for perinatal neuroprotection? Neural Regen Res. 2023 Jan;18(1):47-50.
- Stojanovska V, Atta J, Kelly SB, Zahra VA, Matthews-Staindl E, Nitsos I, Moxham A, Pham Y, Hooper SB, Herlenius E, Galinsky R, Polglase GR (2022). Increased Prostaglandin E2 in Brainstem Respiratory Centers Is Associated With Inhibition of Breathing Movements in Fetal Sheep Exposed to Progressive Systemic Inflammation. Front Physiol. 2022 Mar 3;13:841229.
- Tran NT, Kelly SB, Snow RJ, Walker DW, Ellery SJ, Galinsky R (2021). Assessing Creatine Supplementation for Neuroprotection against Perinatal Hypoxic-Ischaemic Encephalopathy: A Systematic Review of Perinatal and Adult Pre-Clinical Studies. Cells. 2021 Oct 27;10(11):2902.
- Galinsky R, Dhillon SK, Kelly SB, Wassink G, Davidson JO, Lear CA, van den Heuij LG, Bennet L, Gunn AJ (2023). Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep. J Physiol. 2023 Mar 31.
- Green EA, Metz D, Galinsky R, Atkinson R, Skuza EM, Clark M, Gunn AJ, Kirkpatrick CM, Hunt RW, Berger PJ, Nold-Petry CA, Nold MF (2022). Anakinra Pilot – a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants. Front Immunol. 2022 Oct 27;13:1022104.
- Kelly SB, Green E, Hunt RW, Nold-Petry CA, Gunn AJ, Nold MF, Galinsky R (2023). Interleukin-1: an important target for perinatal neuroprotection? Neural Regen Res. 2023 Jan;18(1):47-50.
- Stojanovska V, Atta J, Kelly SB, Zahra VA, Matthews-Staindl E, Nitsos I, Moxham A, Pham Y, Hooper SB, Herlenius E, Galinsky R, Polglase GR (2022). Increased Prostaglandin E2 in Brainstem Respiratory Centers Is Associated With Inhibition of Breathing Movements in Fetal Sheep Exposed to Progressive Systemic Inflammation. Front Physiol. 2022 Mar 3;13:841229.
- Tran NT, Kelly SB, Snow RJ, Walker DW, Ellery SJ, Galinsky R (2021). Assessing Creatine Supplementation for Neuroprotection against Perinatal Hypoxic-Ischaemic Encephalopathy: A Systematic Review of Perinatal and Adult Pre-Clinical Studies. Cells. 2021 Oct 27;10(11):2902.